2-(6,6-Difluorospiro[3.3]heptan-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Catalog No. :
ACUBJC359
CAS No. :
2454202-08-3
Molecular Formula :
C13H21BF2O2
Molecular Weight :
258.12

IUPAC Name:2-(6,6-difluorospiro[3.3]heptan-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(6,6-Difluorospiro[3.3]heptan-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$849.00Login to see priceIn stockInquiry
250mg98%$1698.00Login to see priceInquiryInquiry
500mg98%$2546.00Login to see priceInquiryInquiry
1g98%$4244.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(6,6-Difluorospiro[3.3]heptan-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
IUPAC Name2-(6,6-difluorospiro[3.3]heptan-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
MDL No.MFCD35091434
Molecular FormulaC13H21BF2O2
Molecular Weight258.12
SMILESCC1(C)C(C)(C)OB(C2CC3(CC(F)(F)C3)C2)O1
InChI KeyGZIBSBUTHMOMSG-UHFFFAOYSA-N
Synonym2-(6,6-Difluorospiro[3.3]heptan-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;6,6-Difluorospiro[3.3]heptane-2-boronic Acid Pinacol Ester
CAS No.2454202-08-3

Synthetic Route by SureRoute

1. ACUBJC359 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACTMEX940 route compound structure diagram
    ACTMEX9402137641-05-3 In Stock
  4. Then
  5. ACUBJC359 route product structure diagram
    ACUBJC3592454202-08-3 In Stock
Inquiry

2. ACUBJC359 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACMQQM253 route compound structure diagram
    ACMQQM2532408974-56-9
  4. Then
  5. ACUBJC359 route product structure diagram
    ACUBJC3592454202-08-3 In Stock
Inquiry

Comments (0)